---
title: "Catheter Precision, Inc. (VTAK.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/VTAK.US.md"
symbol: "VTAK.US"
name: "Catheter Precision, Inc."
industry: "醫療器械"
---

# Catheter Precision, Inc. (VTAK.US)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 美股市場 |
| Website | [www.catheterprecision.com](https://www.catheterprecision.com) |

## Company Profile

Catheter Precision, Inc. 設計、制造並銷售用于心臟電生理（EP）領域的醫療技術。該公司的主打產品是 View into Ventricular Onset System，這是一種非侵入性成像系統，提供 3D 心臟映射，幫助定位結構正常心臟患者的特發性室性心律失常的起源部位，以便在 EP 過程中使用。它還提供 LockeT，這是一種縫合線保持裝置，可以暫時固定縫合線，並幫助臨床醫生定位和移除縫合線

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-22T04:30:14.000Z

**Overall: D (0.64)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 150 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 82.96% |  |
| Net Profit YoY | -89.93% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.43 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.89M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 730000.00 |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -226.35% | E |
| Profit Margin | -2333.29% | E |
| Gross Margin | 92.04% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 82.96% | A |
| Net Profit YoY | -89.93% | E |
| Total Assets YoY | -4.76% | D |
| Net Assets YoY | -49.72% | E |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -3.29% | D |
| OCF YoY | 82.96% | A |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.03 | E |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 74.68% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Catheter Precision, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-226.35%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-2333.29%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "92.04%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "82.96%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-89.93%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-4.76%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-49.72%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-3.29%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "82.96%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.03",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "74.68%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 啟迪醫療 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 直覺外科 (US.ISRG) | A | B | C | A | B | B |
| 04 | 史賽克 (US.SYK) | A | B | C | C | B | B |
| 05 | 波士頓科學 (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.13 | 56/181 | - | - | - |
| PB | 0.43 | 10/181 | 0.53 | 0.44 | 0.25 |
| PS (TTM) | 3.95 | 79/181 | 6.64 | 5.90 | 4.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-11-12T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.35 |
| Highest Target | 38.00 |
| Lowest Target | 38.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/VTAK.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/VTAK.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/VTAK.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.